Raymond James Financial Services Advisors’s Kalaris Therapeutics KLRS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio KLRS Stock Details KLRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$48.9K	Hold
2024 Q2	$43.8K	Hold
2024 Q1	$45.7K	Buy
2023 Q4	$22.7K	Buy